Lanean...
Searching for the Chokehold of NRAS Mutant Melanoma
Up to 18% of melanomas harbor mutations in the neuroblastoma rat-sarcoma homolog (NRAS). Yet, decades of research aimed to interfere with oncogenic RAS signaling have been largely disappointing and have not resulted in meaningful clinical outputs. Recent advances in disease modeling, structural biol...
Gorde:
| Argitaratua izan da: | J Invest Dermatol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4921268/ https://ncbi.nlm.nih.gov/pubmed/27160069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2016.03.006 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|